Immunoglobulins, Intravenous
"Immunoglobulins, Intravenous" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Immunoglobulin preparations used in intravenous infusion, containing primarily IMMUNOGLOBULIN G. They are used to treat a variety of diseases associated with decreased or abnormal immunoglobulin levels including pediatric AIDS; primary HYPERGAMMAGLOBULINEMIA; SCID; CYTOMEGALOVIRUS infections in transplant recipients, LYMPHOCYTIC LEUKEMIA, CHRONIC; Kawasaki syndrome, infection in neonates, and IDIOPATHIC THROMBOCYTOPENIC PURPURA.
MeSH Number(s)
D12.776.124.486.485.114.619.393.536
D12.776.124.486.485.114.632
D12.776.124.790.651.114.632
D12.776.377.715.548.114.632
Concept/Terms
Immunoglobulins, Intravenous- Immunoglobulins, Intravenous
- Immune Globulin, Intravenous
- Intravenous Immune Globulin
- IVIG
- Intravenous IG
- Intravenous Immunoglobulins
- IV Immunoglobulins
- Immunoglobulins, IV
- Antibodies, Intravenous
- Intravenous Antibodies
Below are MeSH descriptors whose meaning is more general than "Immunoglobulins, Intravenous".
Below are MeSH descriptors whose meaning is more specific than "Immunoglobulins, Intravenous".
This graph shows the total number of publications written about "Immunoglobulins, Intravenous" by people in Harvard Catalyst Profiles by year, and whether "Immunoglobulins, Intravenous" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 6 | 4 | 10 |
| 1995 | 2 | 0 | 2 |
| 1996 | 8 | 4 | 12 |
| 1997 | 4 | 2 | 6 |
| 1998 | 3 | 3 | 6 |
| 1999 | 3 | 4 | 7 |
| 2000 | 4 | 4 | 8 |
| 2001 | 9 | 8 | 17 |
| 2002 | 3 | 2 | 5 |
| 2003 | 6 | 4 | 10 |
| 2004 | 6 | 7 | 13 |
| 2005 | 3 | 7 | 10 |
| 2006 | 2 | 2 | 4 |
| 2007 | 7 | 3 | 10 |
| 2008 | 7 | 5 | 12 |
| 2009 | 3 | 7 | 10 |
| 2010 | 8 | 6 | 14 |
| 2011 | 3 | 6 | 9 |
| 2012 | 5 | 8 | 13 |
| 2013 | 2 | 7 | 9 |
| 2014 | 5 | 6 | 11 |
| 2015 | 8 | 6 | 14 |
| 2016 | 9 | 9 | 18 |
| 2017 | 10 | 7 | 17 |
| 2018 | 12 | 6 | 18 |
| 2019 | 9 | 9 | 18 |
| 2020 | 19 | 20 | 39 |
| 2021 | 10 | 12 | 22 |
| 2022 | 5 | 18 | 23 |
| 2023 | 4 | 5 | 9 |
| 2024 | 2 | 1 | 3 |
Below are the most recent publications written about "Immunoglobulins, Intravenous" by people in Profiles.
-
An engineered immunomodulatory IgG1 Fc suppresses autoimmune inflammation through pathways shared with i.v. immunoglobulin. J Clin Invest. 2024 Feb 15; 134(4).
-
Effectiveness of immunotherapies in relapsing myelin oligodendrocyte glycoprotein antibody-associated disease. Mult Scler. 2024 Mar; 30(3):357-368.
-
Predictors of relapsing disease course following index event in myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD). J Neurol Sci. 2024 Mar 15; 458:122909.
-
Early Treatment of Multisystem Inflammatory Syndrome in Children. Pediatrics. 2023 09 01; 152(3).
-
Intravenous immunoglobulin treatment for acute attacks in myelin oligodendrocyte glycoprotein antibody disease. Mult Scler. 2023 08; 29(9):1080-1089.
-
Hyaluronidase-facilitated subcutaneous immunoglobulin 10% as maintenance therapy for chronic inflammatory demyelinating polyradiculoneuropathy: The ADVANCE-CIDP 1 randomized controlled trial. J Peripher Nerv Syst. 2023 09; 28(3):436-449.
-
Immunomodulatory Therapy for MIS-C. Pediatrics. 2023 Jul 01; 152(1).
-
Trends in mortality and morbidity in patients with bullous pemphigoid before and after approval of intravenous immunoglobulin in Japan: an interrupted time-series analysis. Clin Exp Dermatol. 2023 Jun 05; 48(6):667-673.
-
Intravenous Immunoglobulin and Dermatomyositis-Associated Venous Thromboembolism. JAMA Dermatol. 2023 06 01; 159(6):666-667.
-
Variation in Early Anakinra Use and Short-Term Outcomes in Multisystem Inflammatory Syndrome in Children. Arthritis Rheumatol. 2023 08; 75(8):1466-1476.